siltuximab monoclonal antibody drug. targets interleukin-6 receptor and is approved for the treatment of rheumatoid arthritis.

angiofollicular antibody arthritis biological biosimilar biotech biotechnology cancer castleman chimeric cytokine disease drug giant hamartoma hyperplasia il6 immunoglobulin immunology infusion injection inn interleukin interleukin6 lymph lymphoid lymphoproliferative mab macrophage mcd monoclonal multicentric muscle myokine node nomenclature peptide prostate protein renal rheumatoid siltuximab